On June 17, 2025, Acurx Pharmaceuticals, Inc. entered into a warrant inducement agreement allowing a holder to exercise existing warrants for a total of 4,445,435 shares at $0.60 each and receive new warrants for additional shares at $0.425 each, expected to raise approximately $2.3 million for corporate purposes.